Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 63.4 EUR 6.55% Market Closed
Market Cap: 613.7m EUR

Operating Margin

21.8%
Current
Declining
by 2.2%
vs 3-y average of 24%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
21.8%
=
Operating Income
€39.3m
/
Revenue
€180.4m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
21.8%
=
Operating Income
€39.3m
/
Revenue
€180.4m

Peer Comparison

Country Company Market Cap Operating
Margin
IT
Pharmanutra SpA
MIL:PHN
608.1m EUR
Loading...
FR
L'Oreal SA
PAR:OR
203B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
116.6B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
32.4B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
41.5B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.3B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
909.5B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...
No Stocks Found

Market Distribution

Higher than 83% of companies in Italy
Percentile
83rd
Based on 1 199 companies
83rd percentile
21.8%
Low
-79 476% — 3.9%
Typical Range
3.9% — 14.4%
High
14.4% — 813.7%
Distribution Statistics
Italy
Min -79 476%
30th Percentile 3.9%
Median 8.7%
70th Percentile 14.4%
Max 813.7%

Pharmanutra SpA
Glance View

Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

PHN Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
21.8%
=
Operating Income
€39.3m
/
Revenue
€180.4m
What is Pharmanutra SpA's current Operating Margin?

The current Operating Margin for Pharmanutra SpA is 21.8%, which is below its 3-year median of 24%.

How has Operating Margin changed over time?

Over the last 3 years, Pharmanutra SpA’s Operating Margin has decreased from 27.9% to 21.8%. During this period, it reached a low of 21.8% on Oct 30, 2025 and a high of 28% on Mar 31, 2023.

Back to Top